V1 sact_drug_detail
6,385,827 rows · 11 columns
| MERGED_DRUG_DETAIL_ID | MERGED_CYCLE_ID | ORG_CODE_OF_DRUG_PROVIDER | ACTUAL_DOSE_PER_ADMINISTRATION | OPCS_DELIVERY_CODE | ADMINISTRATION_ROUTE | ADMINISTRATION_DATE | DRUG_GROUP | MERGED_PATIENT_ID | MERGED_TUMOUR_ID | MERGED_REGIMEN_ID |
|---|---|---|---|---|---|---|---|---|---|---|
| 16674037 | 330028810 | EEX02 | 450 | X721 | 1 | 2017-08-26 | NOT CHEMO | 330008066 | 330010428 | 330007176 |
| 16674038 | 330028810 | EGENG | 10 | X729 | 1 | 2017-08-26 | CLADRIBINE | 330008066 | 330010428 | 330007176 |
| 16674039 | 330028810 | EUDUU | 125 | null | 5 | 2017-08-26 | DACTINOMYCIN | 330008066 | 330010428 | 330007176 |
| 16674040 | 330028810 | EGX01 | 350 | null | 5 | 2017-09-02 | BORTEZOMIB | 330008066 | 330010428 | 330007176 |
| 16674041 | 330028811 | EU8 | 100 | X724 | 2 | 2017-02-19 | CYCLOPHOSPHAMIDE | 330008104 | 330003971 | 330007186 |
| 16674042 | 330028811 | EWR01 | 500 | null | 5 | 2017-02-19 | NOT CHEMO | 330008104 | 330003971 | 330007186 |
| 16674043 | 330028811 | ESFQN | null | null | 1 | 2017-02-20 | CLADRIBINE | 330008104 | 330003971 | 330007186 |
| 16674044 | 330028811 | EUDUU | 40 | X721 | 2 | 2017-02-20 | NOT CHEMO | 330008104 | 330003971 | 330007186 |
| 16674045 | 330028811 | EEX02 | 3 | null | 1 | 2017-02-20 | VINCRISTINE | 330008104 | 330003971 | 330007186 |
| 16674046 | 330028811 | EE105 | 125 | null | 11 | 2017-02-21 | CISPLATIN | 330008104 | 330003971 | 330007186 |
| 16674047 | 330028811 | EUH | 4 | X721 | 1 | 2017-02-21 | NOT CHEMO | 330008104 | 330003971 | 330007186 |
| 16674048 | 330028811 | EE813 | 4640 | null | 1 | 2017-02-22 | METHOTREXATE | 330008104 | 330003971 | 330007186 |
| 16674049 | 330028811 | ELW | 1.7 | X723 | 1 | 2017-02-23 | CARBOPLATIN | 330008104 | 330003971 | 330007186 |
| 16674050 | 330028811 | EUZ | 20 | null | 1 | 2017-02-23 | GEMCITABINE | 330008104 | 330003971 | 330007186 |
| 16674051 | 330028811 | EK1EN | 225 | null | 1 | 2017-02-23 | VINCRISTINE | 330008104 | 330003971 | 330007186 |
| 16674052 | 330028811 | E1UZ0 | 20 | X721 | 1 | 2017-02-23 | MESNA | 330008104 | 330003971 | 330007186 |
| 16674053 | 330028811 | EKY01 | 200 | null | 1 | 2017-02-24 | VINORELBINE | 330008104 | 330003971 | 330007186 |
| 16674054 | 330028811 | EEI00 | 1300 | null | 5 | 2017-02-25 | ETOPOSIDE | 330008104 | 330003971 | 330007186 |
| 16674055 | 330028811 | EJU04 | 220 | null | 1 | 2017-02-25 | PERTUZUMAB | 330008104 | 330003971 | 330007186 |
| 16674056 | 330028811 | ECL02 | 8 | null | null | 2017-02-25 | FLUDARABINE | 330008104 | 330003971 | 330007186 |
| 16674057 | 330028811 | EEI00 | 110 | X724 | 1 | 2017-02-25 | CYTARABINE | 330008104 | 330003971 | 330007186 |
| 16674058 | 330028813 | EJU04 | 500 | X722 | 1 | 2015-01-20 | CETUXIMAB | 330008208 | 330004007 | 330007214 |
| 16674059 | 330028813 | EKS | 500 | X723 | 1 | 2015-01-20 | STEROID | 330008208 | 330004007 | 330007214 |
| 16674060 | 330028814 | EJS03 | 8 | X724 | 1 | 2015-12-20 | STEROID | 330008268 | 330004023 | 330007224 |
| 16674061 | 330028816 | EJR | 400 | null | 1 | 2015-05-02 | CETUXIMAB | 330008299 | 330008195 | 330007232 |
| 16674062 | 330028816 | EEX02 | 8 | null | 1 | 2015-05-08 | CETUXIMAB | 330008299 | 330008195 | 330007232 |
| 16674063 | 330028816 | EGT | 11 | X724 | 1 | 2015-05-08 | CLADRIBINE | 330008299 | 330008195 | 330007232 |
| 16674064 | 330028816 | EZ1 | 500 | X721 | 2 | 2015-05-09 | CISPLATIN | 330008299 | 330008195 | 330007232 |
| 16674065 | 330028817 | EWR01 | 100 | X721 | 1 | 2016-12-28 | NOT CHEMO | 330008305 | 330004034 | 330007235 |
| 16674066 | 330028817 | EA325 | 10 | X724 | 1 | 2016-12-28 | CLADRIBINE | 330008305 | 330004034 | 330007235 |
| 16674067 | 330028818 | EJU04 | 5650 | null | 1 | 2013-05-20 | CARBOPLATIN | 330008309 | 330010448 | 330007236 |
| 16674068 | 330028818 | EU8 | 100 | X724 | 1 | 2013-05-24 | CYCLOPHOSPHAMIDE | 330008309 | 330010448 | 330007236 |
| 16674069 | 330028819 | EJU04 | 5650 | null | 1 | 2017-03-28 | STEROID | 330008309 | 330010448 | 330007237 |
| 16674070 | 330028819 | EJU04 | 500 | X724 | 1 | 2017-04-04 | CETUXIMAB | 330008309 | 330010448 | 330007237 |
| 16674071 | 330028819 | ESFQN | 8 | X729 | 2 | 2017-04-04 | CLADRIBINE | 330008309 | 330010448 | 330007237 |
| 16674072 | 330028819 | EW100 | 5900 | X721 | 2 | 2017-04-04 | MULTIPLE | 330008309 | 330010448 | 330007237 |
| 16674073 | 330028819 | ED301 | 10 | X723 | 1 | 2017-04-04 | VINCRISTINE | 330008309 | 330010448 | 330007237 |
| 16674074 | 330028819 | EAYNL | 60 | null | 2 | 2017-04-04 | VINORELBINE | 330008309 | 330010448 | 330007237 |
| 16674075 | 330028820 | EJU04 | 500 | null | 1 | null | CETUXIMAB | 330008351 | 330004037 | 330007241 |
| 16674076 | 330028820 | E1UZ0 | 480 | null | 2 | null | CYCLOPHOSPHAMIDE | 330008351 | 330004037 | 330007241 |
| 16674077 | 330028820 | EA325 | 5 | X723 | 1 | null | CLADRIBINE | 330008351 | 330004037 | 330007241 |
| 16674078 | 330028821 | EN201 | 370 | X724 | 1 | 2018-08-07 | FLUOROURACIL | 330008351 | 330004037 | 330007242 |
| 16674079 | 330028821 | ea506 | 8 | X724 | 1 | 2018-08-07 | RITUXIMAB | 330008351 | 330004037 | 330007242 |
| 16674080 | 330028821 | E1UZ0 | 7.2 | X722 | 2 | 2018-08-07 | RITUXIMAB | 330008351 | 330004037 | 330007242 |
| 16674081 | 330028821 | EW100 | 125 | X721 | 1 | 2018-08-07 | ETOPOSIDE | 330008351 | 330004037 | 330007242 |
| 16674082 | 330028821 | EEX02 | 6 | null | 1 | 2018-08-07 | DOXORUBICIN | 330008351 | 330004037 | 330007242 |
| 16674083 | 330028822 | EE813 | 445 | X721 | 1 | 2016-07-24 | CETUXIMAB | 330008370 | 330004044 | 330007247 |
| 16674086 | 330028824 | EJS03 | 500 | null | 1 | 2017-03-06 | CETUXIMAB | 330008382 | 330008204 | 330007249 |
| 16674087 | 330028824 | ETG | 5 | null | 2 | 2017-03-06 | CLADRIBINE | 330008382 | 330008204 | 330007249 |
| 16674088 | 330028824 | EU8 | 20 | null | 2 | 2017-03-06 | CYCLOPHOSPHAMIDE | 330008382 | 330008204 | 330007249 |